hoffmann6383 @hoffmann6383 Twitter profile

Pinned Tweet

hoffmann6383

1 year

I wrote an article about $NWBO: I encourage everyone to read it. What is happening with NWBO is astounding and our persistent retail investor has hung on through it all. I believe we will all be much better off when this story comes to its' ending.

From the NWBO community on Reddit: The American System - Profits Over Life; $NWBO’s Battle to Bring...

Explore this post and more from the NWBO community

www.reddit.com

43

123

365

Last Seen Profiles

@AshleyVAlford

@CShirlena28629

@cbzkslkssksls

@Kinomensch

@IshaqYu

@soresono88

@excell305

@kenziemichelle3

@James5619856294

@AngeloTham5310

@WiroSab88861550

@NamiraSharhana

@CianaKenri66151

@PenKimdayo

@FANRUAE

@LShonteria64183

@TWynona34683

@_Jenoona_

@ya71742

@nvidia

@AndreLonardi

@eridiumdreams

@bigcat_mia

@little8biscuits

@pianoramix

@ETurnham52296

@SiBishop

@stw46

@Al_azani2020

@sa_q5_5

@uwteam

@hyunhodiary

@killalady1

@NguyenV43167762

@mmdllwn10415441

@jandakembangstw

hoffmann6383

@hoffmann6383

2 months

🚨The walls are closing in on hedge funds engaged in illegal market manipulation🚨 Innocent hedge funds typically don't hide from a process server and then refuse to turn over ANY documents In this post we'll explore certain hedge fund actions in an ongoing spoofing case in the

26

229

635

hoffmann6383

@hoffmann6383

11 months

📢Oral Argument Update📢 $NWBO v. @citsecurities , et al, Case No 1:22-cv-10185-GHW-GWG The Spoofing Lawsuit NWBO’s lawsuit alleges 2,849 episodes of spoofing $NWBO's stock over a five year period by market makers Canaccord Genuity LLC, Citadel Securities LLC, G1 Execution

43

80

298

hoffmann6383

@hoffmann6383

7 months

📢Northwest Biotherapeutics Second Amended Complaint📢 $NWBO The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) In this post I'll go over the highlights of the Second Amended Complaint filed on 3-15-24 and then offer some thoughts.

36

59

241

hoffmann6383

@hoffmann6383

15 days

⚖️It APPEARS that we have the FIRST spoofing settlement by a market maker in an ongoing Southern District of New York case⚖️ The Case: Harrington Global Opportunity Fund, Limited v. BofA Securities, Inc., 1:21-cv-00761, (S.D.N.Y.) Recall, on September

13

80

244

hoffmann6383

@hoffmann6383

10 months

🧑‍⚖️Magistrate Judge Stein's MTD Report & Recommendation🧑‍⚖️ The Case: $NWBO v. @citsecurities , et al, Case No 1:22-cv-10185-GHW-GWG Recommendation & Report "...the Court respectfully recommends that Defendant's motion be GRANTED due to the Plaintiff's failure to adequately plead

39

44

205

hoffmann6383

@hoffmann6383

27 days

📥Good News for NWBO's Settlement Prospects📤 See Image below. This is the first sign of settlement negotiations we've seen in a civil spoofing case to date. The spoofing case, Harrington, is at the tail end of discovery and the parties appear to have sat for a settlement

18

47

208

hoffmann6383

@hoffmann6383

10 months

Defendant's Request for a 30 day extension to file objections to Magistrate Judge Stein's Report and Recommendation: Denied. $NWBO

22

47

203

hoffmann6383

@hoffmann6383

5 months

📣Public Service Announcement: INNOCENT PARTIES DO HOT HIDE📣 $NWBO Third Parties allegedly involved in illegal share price manipulation (spoofing) appear to be avoiding being served a subpoena for documents. These third parties are clients of market makers. Likely hedge funds

19

53

195

hoffmann6383

@hoffmann6383

4 months

🗞️NWBO Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property🗞️ $NWBO The Press Release June 17, 2024 PR: "Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax®

14

39

188

hoffmann6383

@hoffmann6383

8 months

✅️NICE Update✅️ $NWBO "05 March 2024 A meeting was held between NICE and the company in early-February regarding next steps for the appraisal of DCVax-L for treating glioblastoma, and more information will be available in due course. NICE will continue liaising with the

13

36

185

hoffmann6383

@hoffmann6383

2 months

🩸Impeding Innovation and Costing Lives🩸 $NWBO investors have been saying it for years, but now we see it neatly spelled out in an academic paper: Hedge funds and Market Makers are engaged in the illegal manipulation of $NWBO stock all to make a buck at the expenses of real

9

52

180

hoffmann6383

@hoffmann6383

1 year

$NWBO v. @citsecurities , et al., 1:22-cv-10185-GHW-GWG ➡️A Positive Development on Damages⬅️ The Court in Harrington found it plausible that spoofing could lead to a permanent price impact [1] Bottom Line: ✅This could allow NWBO to claim damages on 283 million shares sold

8

43

178

hoffmann6383

@hoffmann6383

9 months

🧑‍⚖️ $NWBO's Closing Arguments on the Motion to Dismiss🧑‍⚖️ The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) Plaintiff: Northwest Biotherapeutics, Inc. $NWBO Defendants: Canaccord Genuity, LLC @CG_Driven , Citadel Securities, LLC

28

34

176

hoffmann6383

@hoffmann6383

9 months

$NWBO The American System - Profits Over Life; A Tiny Biotech's Battle to Bring a Cancer Vaccine to Market Posted over at r/Wallstreetbets with MAA submission updates:

From the wallstreetbets community on Reddit

Explore this post and more from the wallstreetbets community

www.reddit.com

14

54

177

hoffmann6383

@hoffmann6383

9 months

🛠️Flaskworks: ~$4.33m Well Spent🛠️ Well done to $NWBO, Advent BioServices, and the Flaskworks teams on the progress outlined in today's Flaskworks PR. I'll give a timeline of how we got here and then a summary of today's PR. August 28, 2020 [1]: $NWBO acquires Flaskworks for

12

45

176

hoffmann6383

@hoffmann6383

3 months

🟢Progressing with the MAA🟢 $NWBO Inspections have been scheduled. See Image. That's great to hear considering the last update stated NWBO did not know when inspections were to occur. This bodes well for a fall/winter approval, imo.

17

34

177

hoffmann6383

@hoffmann6383

4 months

⏲️Awaiting Judge Woods’ decision on the MTD⏲️ $NWBO The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) Plaintiff: Northwest Biotherapeutics, Inc. Defendants: Canaccord Genuity LLC, Citadel Securities LLC, G1 Execution Services LLC,

25

43

171

hoffmann6383

@hoffmann6383

5 months

➡️NWBO's Memo in Opposition to Defendants' MTD⬅️ The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) $NWBO has accused seven market makers of illegal share price manipulation. Defendants: Canaccord Genuity LLC, Citadel Securities LLC,

19

33

171

hoffmann6383

@hoffmann6383

6 months

Preprint no longer. $NWBO

TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in...

Nature Communications - Autologous tumor lysate (ATL) dendritic cell (DC) vaccination can induce local and systemic anti-tumor immune responses in malignant glioma patients. In this randomized...

www.nature.com

hoffmann6383

@hoffmann6383

1 year

$NWBO Outstanding results seen with DCVax-L + Poly-ICLC in a preprint Nature journal article [1]. Some additional context to those outstanding results: A MEDIAN OVERALL SURVIVAL COMPARISON (mOS) Standard of Care (SOC) + DCVax-L [2] v. SOC + DCVax-L + Poly-ICLC [3]

5

23

110

11

43

169

hoffmann6383

@hoffmann6383

2 months

🎭Hedge Funds Unmasked🎭 Hedge funds and any other entities spoofing $NWBO's stock will be identified via discovery after/if the MTD is denied. See the below language from yesterday's status conference in another spoofing case in the Southern District of New York where defendant

12

36

167

hoffmann6383

@hoffmann6383

4 months

📰June 29, 2024 NWBO ASM📰 $NWBO In this post I'll include my notes for the ASM and I'll follow it up with some thoughts. FORMAL MEETING 1. To elect two members to our Board of Directors to serve as a Class I Directors for a term of three years; ✅PASSED 2. To ratify

13

29

166

hoffmann6383

@hoffmann6383

11 months

$NWBO 📣11-14-23 Motion to Dismiss Oral Argument - summary coming📣 Northwest Biotherapeutics, Inc v. Canaccord Genuity, LLC, et al. (Case No: 1:22-cv-10185) The oral argument transcript will be an interesting read. The defendants double down on their argument that 2,849

18

27

160

hoffmann6383

@hoffmann6383

6 months

⚖️Defendants’ Joint Memorandum of Law in Support of Motion to Dismiss Second Amended Complaint (“MTD”)⚖️ $NWBO Yesterday the Defendant Market Makers in the NWBO spoofing case filed their MTD NWBO's Second Amended Complaint. The Case: Northwest Biotherapeutics, Inc v. Canaccord

32

26

160

hoffmann6383

@hoffmann6383

2 months

✅The Impact of Spoofing✅ On May 10th, 2022 the results of $NWBO's Phase III DCVax-L trial were released. The results were positive. "On May 10, 2022, positive top-line results from the clinical trial were presented at the Frontiers of Cancer Immunotherapy Conference of the

4

33

154

hoffmann6383

@hoffmann6383

1 year

$NWBO Q3 '23 10Q: RA Submission "The Company is now in the final stages of preparing an application to the U.K. regulatory authority for approval of DCVax-L. The Company is working with teams of specialized consultants on preparation of the

17

25

154

hoffmann6383

@hoffmann6383

10 months

➡️A Day in the Life of a $NWBO Shareholder ⬅️ "No submission this year and maybe next year as well with these asshats." [1] "I don't believe this mgmt will achieve submission." [1] "Dead stock for 2023. Maybe submission by 2024? News 2025?" [2] "There will be no submission in

12

31

146

hoffmann6383

@hoffmann6383

3 months

➡️Q2 '24 10Q⬅️ $NWBO A quick scan of the Q2 Overview as compared to Q1: ✅The Covid delay language has been removed ✅The two (confusing) validation dates were removed ✅Confirmed inspections are scheduled to take place in the US and UK ✅MAA Process language was added

16

25

150

hoffmann6383

@hoffmann6383

9 months

⚖️SUMMARY & THOUGHTS: Plaintiff's Limited Objection to Magistrate Judge Stein's Report and Recommendation Regarding the Element of Loss Causation⚖️ $NWBO BACKGROUND On December 29th, 2023 Magistrate Judge Stein issued his Report and Recommendation (R&R) on Defendant’s Motion

23

33

148

hoffmann6383

@hoffmann6383

1 year

➡️Developing Story Line: A Naked Short Covering Scheme⬅️ $NWBO When following a lawsuit it's interesting to see the different narratives put forth by the Defendant and Plaintiff. On the Plaintiff's side, $NWBO has a developing narrative that the spoofing is being done to

9

33

143

hoffmann6383

@hoffmann6383

3 months

💵Doug Cifu - Grifter Extraordinaire💵 🗓️December 1, 2022 $NWBO filed a lawsuit against seven market makers, including @VirtuFinancial and @citsecurities accusing them of illegal market manipulation, specifically, 2,849 incidents of spoofing over an approximately five year

16

40

143

hoffmann6383

@hoffmann6383

9 months

🧑‍⚖️NWBO Lawsuit Update🧑‍⚖️ In this post I'll provide a quick update on the recent flurry of filings in the $NWBO lawsuit. The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) The Docket: On January 26th $NWBO filed

24

25

143

hoffmann6383

@hoffmann6383

2 months

This is how you lose credibility in a court case. Merrill Lynch Appears to have forgotten to disclose there is a team and computer program tasked with monitoring spoofing in a civil spoofing case accusing Merrill Lynch (and multiple other market makers) of failing to have

7

35

143

hoffmann6383

@hoffmann6383

9 months

📊We are due for a NWBO Corporate Presentation, a/k/a a Slide Deck📊 It's time to tell the world what we as $NWBO shareholders already know. Linda Powers, CEO $NWBO, signaled $NWBO's desire to uplist at the 2022 Annual Shareholder Meeting. She stated it would depend on market

9

22

140

hoffmann6383

@hoffmann6383

11 months

☠️A Hedge Fund Nightmare☠️ $NWBO @citsecurities @VirtuFinancial @Dougielarge @Tiggersdad2 @JWesChristian @mcelarier @AlisonFrankel ✅Harrington Discovery Update Harrington Global Opportunity Fund, Limited v. CIBC World Markets Corp. (1:21-cv-00761) (Hereinafter, "Harrington")

12

51

141

hoffmann6383

@hoffmann6383

10 months

🤔More $MRK & $NWBO Speculation🤔 $MRK January 8, 2024 JPMorgan Conference Presentation. [2] Speakers: Rob Davis, Chairman and Chief Executive Officer Dr. Dean Li, President, Merck Research Laboratories ^^ All $MRK quotes can be attributed to one of these two $MRK: 🔲"…we

9

34

141

hoffmann6383

@hoffmann6383

1 year

Interesting points during the Big Biz Show with Les Goldman, VP of $NWBO. Thanks for the link @HenryMuney ✅“Dendritic cell…bigger thing than our inventors realized at the time…it’s the artificial intelligence of our immune system" ✅We are in the

Big Biz Show - 07.14.2023 by Big Biz Radio Show

Big Biz Show - 07.14.2023 from Big Biz Radio Show on Podchaser, aired Friday, 14th July 2023.

www.podchaser.com

11

38

135

hoffmann6383

@hoffmann6383

1 year

➡️Important Case Law Update⬅️ A ruling was handed down today that is fatal to one of the main arguments found in Defendant's briefs supporting their Motion to Dismiss $NWBO's spoofing lawsuit. In fact, it's fatal to many arguments in Defendant's MTD, but we will focus on one in

12

27

135

hoffmann6383

@hoffmann6383

7 months

🇨🇦Unmasked: Canadian Spoofers🇨🇦 $NWBO The Case: Harrington Global Opportunity Fund, Limited v. BofA Securities, Inc., 1:21-cv-00761, (S.D.N.Y.) Follow up from this post: March 8, 2024 Rule 37.2 Letter by broker-dealer defendant CIBC World Markets,

hoffmann6383

@hoffmann6383

7 months

🤪Discovery is where things get interesting🤪 $NWBO "...CIBC produced a document indicating that customer trading in Concordia generated thousands of alerts triggered by potentially problematic trading activity— including a number flagged for what CIBC deemed possible spoofing

6

12

80

7

33

135

hoffmann6383

@hoffmann6383

5 months

⏳NWBO, Spoofing & the DoJ⌛️ $NWBO $AMC $GME #spoofing @citsecurities , @VirtuFinancial , @LimeTrading_ , @CG_Driven , @gts_capital , @Instinet The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) Market Makers: Canaccord Genuity LLC,

9

35

130

hoffmann6383

@hoffmann6383

1 year

$NWBO Northwest Biotherapeutics, Inc v. Canaccord Genuity, LLC, et al. (Case No: 1:22-cv-10185) Update on Dueling Motion to Dismiss ("MTD") Supplemental Filings First, (1) I'll go through a quick timeline. Second, (2) I'll briefly explore some of Plaintiff and Defendants'

12

32

135

hoffmann6383

@hoffmann6383

1 year

$NWBO ➡️Positive NICE Guidance Updates⬅️ NICE recently updated their guidance to speed up the price reimbursement approval process. This should help $NWBO realize revenue shortly after MHRA approval. ✅The updated NICE guidance applies starting today, November 1st, '23. See

4

22

133

hoffmann6383

@hoffmann6383

2 months

⏳$NWBO's Motion to Dismiss ("MTD") Timeline⌛️ The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) ➡️TIMELINE for MTD NWBO's First Amended Complaint 9-15-23: Press release about the Southern District of New York selecting Gary Stein to

11

19

133

hoffmann6383

@hoffmann6383

7 months

🧑‍🏭Paid Bashing: A full time job🧑‍🏭 $NWBO Who: Inquirig These are his/her posts the week of March 11th (Monday) through March 17th (Sunday). It looks like he/she works from about 9am EST to midnight, 7 days a week with a nice break at dinner. That is a

11

24

134

hoffmann6383

@hoffmann6383

2 years

$NWBO Amended Complaint Exhibit 1: 208 pages of spoofing examples 😵 These are the numbers over a 5 year period for @Citadel ALONE (there are 7 additional defendants with their own record of spoofing): $GME $AMC @InvestorTurf

5

31

132

hoffmann6383

@hoffmann6383

1 year

Yes, Defendants in $NWBO's spoofing case actually made this argument: 'If you stop us from profiting off of illegally manipulating share prices it could upend the entire U.S. equity market system.' 🤷‍♂️🤦‍♂️🤯 @citsecurities @VirtuFinancial

19

34

124

hoffmann6383

@hoffmann6383

2 years

We got it ladies and gents! $NWBO

23

20

132

hoffmann6383

@hoffmann6383

5 months

🧑‍⚖️12 Jurors could control the fate of seven Market Makers, a/k/a Punitive Damages🧑‍⚖️ $NWBO The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) Juror Question What is the appropriate amount of money to punish and deter market markers

7

30

131

hoffmann6383

@hoffmann6383

1 year

$NWBO v. @citsecurities , @VirtuFinancial , et al Lawsuit Update: 6-12-23: Citadel filed a letter requesting a conference to discuss Rule 11 Sanctions against Plaintiff stating NWBO’s claims rely on factually inaccurate allegations Rule 2(A) of Judge Gorstein’s Individual

19

24

128

hoffmann6383

@hoffmann6383

1 year

$NWBO Partnership? "On May 8, 2023, the Company received a $3.0 million prepayment for the purchase of securities for which the terms are in the process of being finalized." 10q:

13

33

127

hoffmann6383

@hoffmann6383

10 months

➡️Mean Processing Time for Acceptance of MAA⬅️ $NWBO MHRA MAA Acceptance Times ✅Mean = 4 days ✅90th percentile = 7 days ✅NWBO's MAA filed 12-20 4 (business) days = December 27th 7 (business) days = January 2nd ^^ Business days excluding Christmas/New Years Expected

10

22

124

hoffmann6383

@hoffmann6383

9 months

$NWBO I usually don't like to do this but lets take a quick look at a repeated narrative pushed by the non invested NWBO posters at @Investors_Hub Specifically, Exwannabe, who has close to 13k posts since 2014 and drowns the forum with false and misleading information:

9

21

124

hoffmann6383

@hoffmann6383

2 months

NWBO Discussed on Big Biz Show Mike Taylor, an "investment banking specialist" who claims to represent $NWBO agreed with a commentator who stated: "...as you get to that 11th hour and that there's going to be a whole bunch of money that comes screaming

08/26/24- Big Biz Show- Howie Font, Gold Royalty Corp., My Patriot...

Sully & Crew talk with Howie Font about non-compete & NDA agreements, and David Garofalo of Gold Royalty Corp. about gold going up and gold in the market. Al...

www.youtube.com

9

26

124

hoffmann6383

@hoffmann6383

5 months

@_AmericanP @rsloftx The quick and dirty....exactly the impression I got when reading the MTD: "Rather than address these well-pled allegations, Defendants baselessly attempt to relitigate elements already found to be sufficient by the Court, and make arguments completely divorced from both the

23

16

123

hoffmann6383

@hoffmann6383

1 year

$NWBO Someone let @adamfeuerstein and @statnews know that it's not grapefruit juice. It's called DCVax-L, per UCLA.

9

22

121

hoffmann6383

@hoffmann6383

11 months

➡️Kenneth C. Griffin v. Reality⬅️ In this post I’ll apply Mr. Griffin’s comments in his recent David Rubenstein interview to the allegations found in a civil suit brought by $NWBO against seven separate broker-dealers, including @citsecurities , to determine if all relevant

13

36

122

hoffmann6383

@hoffmann6383

1 year

$NWBO Lawsuit Update As expected, @CohenMilstein responded within 2 days per the Judge's individual rules. They raise a number of substantive and procedural arguments against @citsecurities 's request for a pre-motion conference for its anticipated Rule 11 sanctions. First,

12

29

121

hoffmann6383

@hoffmann6383

2 years

New, old and potential $NWBO investors - tune in tonight! When: Today at 8:30 PM EST Topic: DC-VAX (Murcidencel) Speaker: Linda Liau, MD, PhD, MBA - the chair of the dept of neurosurgery at UCLA, and Professor and Director of the UCLA Brain Tumor Program

4

30

121

hoffmann6383

@hoffmann6383

2 months

⛪️Hypocrisy, Religion, Aaron Fletcher & NWBO⛪️ $NWBO ➡️Who is Aaron G.L. Fletcher? Managing Director of Bios Partners and President of Bios Research, “a financial services firm that provides public equity research in the healthcare space tailored to institutional firms.” [1]

21

19

121

hoffmann6383

@hoffmann6383

1 year

☑️I believe Dr. Liau is there to help develop $NWBO's pipeline. ☑️I believe the development of the pipeline starts with the combo trials referenced in the recent Q2 '23 10-Q. ☑️I believe Dr. Liau's involvement gives a level of comfort to a future combo trial partner. "We are

1

19

118

hoffmann6383

@hoffmann6383

1 year

$NWBO v. Canaccord Genuity, LLC, Citadel Securities, LLC, G1 Execution Services, GTS Securities LLC, Instinet LLC, Lime Trading Corp., and Virtu Americas LLC ("Defendants") Case 1:22-cv-10185 Motion to Dismiss (MTD) Update - In this post we will go over the prior filings and

13

25

119

hoffmann6383

@hoffmann6383

2 years

$NWBO If it wasn't clear already, FDA just green lighted single arm ECA trials using historical controls with the following Final Guidance Language:

7

19

119

hoffmann6383

@hoffmann6383

11 months

$NWBO ✅The US Market makes up 42.5% of the global equity market capitalization. [1] ✅The gatekeepers entrusted to oversee this enormous market are referred to as market makers. ✅The gatekeepers are allowing themselves and their clients to illegally manipulate the US

3

25

117

hoffmann6383

@hoffmann6383

2 years

Holy sh** $NWBO "...once DCVax gets approved..." Read entire post. These guys are in the know and think approval is imminent.

7

31

119

hoffmann6383

@hoffmann6383

7 months

♟️Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors♟️ $NWBO New NWBO Director, effective 3-18-24: Pat Sarma There isn't much on the internet about Mr. Sarma, but this is what I was able to find:

Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of...

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

www.prnewswire.com

4

17

118

hoffmann6383

@hoffmann6383

1 year

June 3, 2023 $NWBO ASCO Presentation Slide deck entitled DCVax®-L: Mechanism of Action, Immunological Effects, and Clinical Trial External Controls Methodology Conclusions: ✅Mechanism of action studies demonstrate uptake and presentation of a broad range of antigens, which

3

29

118

hoffmann6383

@hoffmann6383

2 months

$NWBO Lock your shares. Turn off lending programs. By making your shares available to loan you are only helping these sort of people: Chris Brown: Aaron Fletcher: Doug Cifu: John Hempton:

hoffmann6383

@hoffmann6383

3 months

💵Doug Cifu - Grifter Extraordinaire💵 🗓️December 1, 2022 $NWBO filed a lawsuit against seven market makers, including @VirtuFinancial and @citsecurities accusing them of illegal market manipulation, specifically, 2,849 incidents of spoofing over an approximately five year

16

40

143

6

32

116

hoffmann6383

@hoffmann6383

8 months

👨‍⚖️Judge Woods Motion to Dismiss Ruling👨‍⚖️ $NWBO The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) On February 14, 2024 Judge Woods granted Defendants’ Motion to Dismiss (“MTD”), with leave to amend. The Order can be found here:

12

20

118

hoffmann6383

@hoffmann6383

9 months

🤔Speculative #DCVax -L Approval Timelines🤔 $NWBO On December 20, 2023, Northwest Biotherapeutics, Inc. (NWBO) submitted their Marketing Authorization Application (MAA) to the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) requesting to be reviewed under the

10

21

117

hoffmann6383

@hoffmann6383

6 months

🧑‍⚖️Harrington Discovery Update: Market Makers are slowly losing the battle to protect the identity of third parties involved in spoofing🧑‍⚖️ $NWBO $BOC @CIBCCM @VirtuFinancial The Case: Harrington Global Opportunity Fund, Limited v. BofA Securities, Inc., 1:21-cv-00761,

10

30

115

hoffmann6383

@hoffmann6383

10 months

This Judge appears to want to hear the case and he keeps his docket moving. I said it before and I'll say it again, this is turning out to be a great Magistrate for the NWBO case.

5

11

115

hoffmann6383

@hoffmann6383

1 year

$NWBO Lock your shares. Turn off margin. Turn off any lending program.

10

15

115

hoffmann6383

@hoffmann6383

5 months

@kshaughnessy2 @hoffman6383 @kshaughnessy2 thanks for all of the reporting that you do and bringing attention to this matter. I believe that both the market makers and their clients (likely hedge funds) in the $NWBO spoofing lawsuit face significant liability from the underlying allegations. It's not just

4

27

115

hoffmann6383

@hoffmann6383

1 year

In light of $NWBO's potential combo trial news I decided to look at the structure of recent $MRK collaborations [1]. A summary of my observations can be seen at the end. Merck & ModeX [2] ☑️Nanoparticle vaccine candidate ☑️MRK to file IND ☑️MRK to handle regulatory

8

20

115

hoffmann6383

@hoffmann6383

1 year

$NWBO "The Company anticipates submitting the MAA in approximately the next 30-45 days." What does this mean for our timeline? Potential approval in the UK January 25/26 See Image

6

21

113

hoffmann6383

@hoffmann6383

11 months

🌍Global Manufacturing License🌍 $NWBO This appears to be one of the first public examples I've seen of our global license at work. "Under this commercial manufacturing license, cell therapy products manufactured in the Sawston facility may be exported globally. Products

2

26

114

hoffmann6383

@hoffmann6383

1 year

Congrats to @CohenMilstein on your record setting $1,000,000,000 settlement with @WellsFargo . Special congrats to Laura Posner, a lead attorney in the below case and lead attorney in $NWBO's lawsuit against @citsecurities and other market makers for 2,800+ incidents of illegal

2

26

113

hoffmann6383

@hoffmann6383

4 months

📢NWBO 2024 ASM Thoughts📢 $NWBO I wanted to get these thoughts out while they're fresh on my mind and before talking with anyone. So, without further ado, my unfiltered initial impressions of the ASM comments: ✅I'm glad all of the resolutions passed. Not that I'm happy

15

10

114

hoffmann6383

@hoffmann6383

1 year

$NWBO "As the therapy awaits submission for approval to the U.S. Food and Drug Administration, it is one of the latest examples of UCLA Health research moving from the bench to the bedside."

FDA approvals may move UCLA brain cancer and Alzheimer’s treatments from bench to bedside

“An institution like UCLA offers patients with progressive and ultimately life-ending diseases the opportunity to participate in trials that may benefit them, but the primary goal of any clinical...

www.uclahealth.org

5

28

111

hoffmann6383

@hoffmann6383

11 months

➡️ $NWBO MAA Timelines & Progress Updates ⬅️ I'll quickly go over the estimated MAA submission timelines and the incremental progress we have seen with the last three MAA PRs. 1⃣ 8-29-23 Press Release Submission: September 28 to October 13 Progress:

Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of...

For immediate release on August 29, 2023 BETHESDA, MD, August 29, 2023 – Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies...

nwbio.com

8

23

114

hoffmann6383

@hoffmann6383

6 months

🍞Combination Trial(s) - Another Breadcrumb🍞 We've been hearing about potential combination trials from $NWBO for just under a year. The references have been getting more detailed as time moves on which makes me hope we are closer to seeing an announcement. The most recent

6

22

112

hoffmann6383

@hoffmann6383

2 years

$NWBO #NWBO These are the kind of results that get you approval with the FDA, EMA, MHRA and Health Canada

4

23

110

hoffmann6383

@hoffmann6383

8 months

📰'Spoofing' case might draw back curtain on high-speed trading firms📰 The Article: The Author: @JoeMillerJr @FT Great article Mr. Miller. Love your opening, which about sums it up: "File under: huge if true." While I'm admittedly a $NWBO investor

‘Spoofing’ case might draw back curtain on high-speed trading firms

Seven broker-dealers including Citadel Securities face a challenge from a cancer vaccine company

www.ft.com

3

30

111

hoffmann6383

@hoffmann6383

7 months

🕑MTD Briefing Timeline🕑 $NWBO The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) What we see going on with recent filings is a battle by the parties to set the briefing schedule for the MTD. Plaintiff's (NWBO) recommendations are

10

17

113

hoffmann6383

@hoffmann6383

7 months

➡️Update: MTD Briefing Schedule Order⬅️ $NWBO The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) Court Ordered Deadlines (pages) See Image 1. May 1, 2024: MTD + Support Docs (25) May 31, 2024: $NWBO's opposition (25) June 14, 2024:

11

19

113

hoffmann6383

@hoffmann6383

1 year

$NWBO $MRK DCVax-L/Poly-ICLC trial: #NCT01204684 The unreviewed preprint journal article is available here: AUTHORS See Image 3 below. Note: All UCLA & Oncovir Founder. THE STUDY "In this study, we report the long-term

3

24

112

hoffmann6383

@hoffmann6383

1 year

$NWBO Outstanding results seen with DCVax-L + Poly-ICLC in a preprint Nature journal article [1]. Some additional context to those outstanding results: A MEDIAN OVERALL SURVIVAL COMPARISON (mOS) Standard of Care (SOC) + DCVax-L [2] v. SOC + DCVax-L + Poly-ICLC [3]

5

23

110

hoffmann6383

@hoffmann6383

1 year

$NWBO v. @citsecurities , et al, lawsuit update on recent flurry of letters: 5-25: NWBO letter to Court submitting a revised Exhibit 1 (ministerial transcription errors) to the 1st Amended Complaint 5-26: Atty Burck on behalf of Citadel Securities, LLC, Canaccord Genuity LLC

8

24

108

hoffmann6383

@hoffmann6383

6 months

⚾️SWING AND A MISS: Market Maker(s) & Hedge Fund(s) failure to properly set up their scapegoat, Adam Feuerstein⚾️ $NWBO filed a lawsuit against seven market makers accusing them of illegally spoofing NWBO’s stock. Spoofing is a way to illegally manipulate a stock price either up

18

26

107

hoffmann6383

@hoffmann6383

5 months

💰Meet Michael Castor, Managing Director of Sio Capital Management and newest NWBO institutional investor💰 $NWBO June 4, 2024 8-K “On June 4, 2024, Northwest Biotherapeutics, Inc. (the “Company”) entered into a Stock Purchase Agreement (SPA) with SIO Capital Management

13

20

109

hoffmann6383

@hoffmann6383

5 months

📢A Credible Expert is Key to a Guilty Spoofing Verdict - Meet Professor Kumar Venkataraman📢 The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.) In the above referenced $NWBO spoofing case the Defendant Market Makers brought up

5

20

110

hoffmann6383

@hoffmann6383

2 months

🇬🇧DCVax-L and the UK's Cancer Drug Fund🇬🇧 $NWBO The Cancer Drug Fund in the UK is a potential DCVax-L funding source between MAA approval and NICE/NHS reimbursement. ❓What are the objectives of the Cancer Drug Fund ("CDF")❓ Guidance found here: The

2

29

107

hoffmann6383

@hoffmann6383

1 year

$NWBO ✅Canadian Oncologist: "...my understanding is that it's being presented to Health Canada..." (link #1 ) ✅US Healthcare provider: "DCVax-L is currently being vetted for possible US Food and Drug Administration approval." (link #2 ) ✅UK: MIA done. PIP reviewed on an

2

25

109

hoffmann6383

@hoffmann6383

7 months

✅The EndBrainCancer Initiative (EBCI): Preparing for DCVax-L Advocacy with the FDA?✅ $NWBO Founder/President @EndBrainCancer : Dellann Elliott Mydland "The EndBrainCancer Initiative (formerly, The Chris Elliott Fund), was established in May, 2002 by my late husband, Chris

5

20

108

hoffmann6383

@hoffmann6383

8 months

❓What is a Single Technology Appraisal❓ Today we saw a NICE update for $NWBO's #DCVax -L for treating glioblastoma. See Image 1. The "Process" was updated to show "STA Standard". In this post I'll go over a STA, or single technology appraisal. The NHS is legally obliged to

7

25

106

hoffmann6383

@hoffmann6383

7 months

⚠️Beware Market-Makers & Hedge Funds: $NWBO is creating the spoofing lawsuit roadmap for other companies to follow⚠️ $NWBO $PHUN The Case: Phunware, Inc. v. UBS Securities LLC, 1:23-cv-06426, (S.D.N.Y.) This is a spoofing lawsuit. I point out the

6

22

104

hoffmann6383

@hoffmann6383

2 years

$NWBO May 10th didn't happen in a vacuum. Manipulative trading practices were in play.

8

20

104

hoffmann6383

@hoffmann6383

7 months

✅Potential Approval Timelines + Other Milestones✅ $NWBO In this post I'll speculate on some potential MHRA approval timelines for #DCVax -L and what other news we might see between now and approval. Potential MAA Approval Timeline(s) The National 150 day route, as I

8

26

108

hoffmann6383

@hoffmann6383

1 year

📢 $NWBO 📢 Any hedge fund manager, trustee of an endowment fund, mutual fund manager, plan administrator of a pension fund, state officials that oversee retirement funds and anyone that has a fiduciary responsibility in managing their clients’ funds will be staying abreast of

4

19

104

hoffmann6383

@hoffmann6383

8 months

❤️‍🩹The National Institute for Health and Care Excellence ("NICE")❤️‍🩹 $NWBO In this post I look at the potential timeline between MA approval of #DCVax -L and a positive NICE recommendation to the NHS for reimbursement of DCVax-L. What does NICE do? "We evaluate new health

2

20

105